Because it may work on some , and we have nothing else for
Because it may work on some , and we have nothing else for today !!!!
So lets try to save some life's now ,
Lets try to use what we have , lets not BANNED that for us the patients , he said they have enough of this drug...
I must say, reading all the information for weeks now about HCQ and COVID-19 , I asked someone , who is using that for lupus.. to give me 30 tabl of plaqenil 200 mg , ..
And now I am much more relaxed that I have it , and I am very sorry for anyone who go to doctor who dont have a right to prescribe it ....
I do believe that in many it might be working at the beginning , and I am really sorry that possibilities are taken away from many by banning that for doctors use ...
As always IMO...
4
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Yoshiharu Global Stock Faces Major Challenges Yoshiharu Global Co. is currently navigating through turbulent waters, as evidenced by the stock reaching a concerning 52-week low of $2.7. This decline starkly contrasts its previous performance, revealing a significant drop of 43.1% in value over the past year. Investors are reflecting on the broader market conditions and...
Continue Reading
Class Action Lawsuit Filed Against Nextracker Inc. Investors are being informed about a recent class action lawsuit that has been initiated concerning Nextracker Inc. (NASDAQ: NXT). This case was filed on behalf of all individuals and entities who acquired shares of Nextracker’s common stock during a specified period. Nextracker, known for its innovative solar...
Continue Reading
Boba Mint Holdings Celebrates Impressive Milestones in Gaming Boba Mint Holdings Ltd. (CSE: TNJ) recently announced outstanding milestones in user growth for its flagship blockchain mobile game, Tanjea. Following the last update on user downloads back in May, the company has reported that total downloads for Tanjea have now exceeded 409,670, with an impressive count of...
Continue Reading
Tixel i® Revolutionizes Dry Eye Treatment A recent publication highlights the remarkable advancements Tixel i® has brought to the field of ophthalmology, particularly for patients dealing with Evaporative Dry Eye Disease (DED) linked to Meibomian Gland Dysfunction (MGD). This cutting-edge technology has gained recognition for its effectiveness in providing long-lasting...
Continue Reading
ClarityPay Enhances Leadership with MJ Panda as COO ClarityPay, a frontrunner in customized point-of-sale credit solutions, has appointed Mrutyunjaya "MJ" Panda as its new Chief Operating Officer. Panda brings with him an impressive background, having held significant roles at both Goldman Sachs and American Express, where he developed a wealth of knowledge in risk...
Continue Reading